AbbVie (ABBV) Receivables - Net (2012 - 2026)
AbbVie (ABBV) posted Receivables - Net of $13.82 billion for Q2 2026, up 9.4% from $12.64 billion a year earlier and up 10.8% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Receivables - Net (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie's Receivables - Net came in at $12.59 billion, up 15.3% from FY2024.
- Annual Receivables - Net shows a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- In prior years, AbbVie's Receivables - Net was $10.92 billion in FY2024 (-2.1%), $11.16 billion in FY2023 (-0.9%), $11.25 billion in FY2022 (+12.8%) and $9.98 billion in FY2021 (+13.1%).
- The Q2 2026 figure stands as the highest quarterly Receivables - Net in data going back to Q4 2012.
- On a year-over-year basis, Receivables - Net increased in six of the last eight quarters, with growth averaging 5.8%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q3 2022, with growth of 15.8%; the weakest was Q4 2024, with a decline of 2.1%.
- According to Business Quant data, Receivables - Net for the three prior quarters was $12.48 billion (Q1 2026), $12.59 billion (Q4 2025) and $12.77 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.82 Bn |
| Mar 31, 2026 | 12.48 Bn |
| Dec 31, 2025 | 12.59 Bn |
| Sep 30, 2025 | 12.77 Bn |
| Jun 30, 2025 | 12.64 Bn |
| Mar 31, 2025 | 12.48 Bn |
| Dec 31, 2024 | 10.92 Bn |
| Sep 30, 2024 | 11.47 Bn |
| Jun 30, 2024 | 11.72 Bn |
| Mar 31, 2024 | 11.95 Bn |
| Dec 31, 2023 | 11.16 Bn |
| Sep 30, 2023 | 11.41 Bn |
| Jun 30, 2023 | 11.49 Bn |
| Mar 31, 2023 | 11.47 Bn |
| Dec 31, 2022 | 11.25 Bn |
| Sep 30, 2022 | 10.74 Bn |
| Jun 30, 2022 | 11.24 Bn |
| Mar 31, 2022 | 10.73 Bn |
| Dec 31, 2021 | 9.98 Bn |
| Sep 30, 2021 | 9.28 Bn |
API Access
AbbVie Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();